The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biologics CDMO Services Market Research Report 2025
Synopsis
The global Biologics CDMO Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biologics CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biologics CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biologics CDMO Services in SMBs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biologics CDMO Services include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, WuXi AppTech, Recipharm, Thermo Fisher Scientific and AGC Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biologics CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics CDMO Services.
Report Scope
The Biologics CDMO Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
WuXi AppTech
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
GenScript
ProBioGen
Northway Biotech
3P Biopharmaceuticals
Segment by Type
Cell and Gene Therapies
Antibodies
Vaccines
Other
Segment by Application
SMBs
Large Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics CDMO Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Biologics CDMO Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biologics CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biologics CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biologics CDMO Services in SMBs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biologics CDMO Services include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, WuXi AppTech, Recipharm, Thermo Fisher Scientific and AGC Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biologics CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics CDMO Services.
Report Scope
The Biologics CDMO Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
WuXi AppTech
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
GenScript
ProBioGen
Northway Biotech
3P Biopharmaceuticals
Segment by Type
Cell and Gene Therapies
Antibodies
Vaccines
Other
Segment by Application
SMBs
Large Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics CDMO Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cell and Gene Therapies
1.2.3 Antibodies
1.2.4 Vaccines
1.2.5 Other
1.3 Market by Application
1.3.1 Global Biologics CDMO Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SMBs
1.3.3 Large Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics CDMO Services Market Perspective (2019-2030)
2.2 Biologics CDMO Services Growth Trends by Region
2.2.1 Global Biologics CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologics CDMO Services Historic Market Size by Region (2019-2024)
2.2.3 Biologics CDMO Services Forecasted Market Size by Region (2025-2030)
2.3 Biologics CDMO Services Market Dynamics
2.3.1 Biologics CDMO Services Industry Trends
2.3.2 Biologics CDMO Services Market Drivers
2.3.3 Biologics CDMO Services Market Challenges
2.3.4 Biologics CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics CDMO Services Players by Revenue
3.1.1 Global Top Biologics CDMO Services Players by Revenue (2019-2024)
3.1.2 Global Biologics CDMO Services Revenue Market Share by Players (2019-2024)
3.2 Global Biologics CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics CDMO Services Revenue
3.4 Global Biologics CDMO Services Market Concentration Ratio
3.4.1 Global Biologics CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics CDMO Services Revenue in 2023
3.5 Biologics CDMO Services Key Players Head office and Area Served
3.6 Key Players Biologics CDMO Services Product Solution and Service
3.7 Date of Enter into Biologics CDMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics CDMO Services Breakdown Data by Type
4.1 Global Biologics CDMO Services Historic Market Size by Type (2019-2024)
4.2 Global Biologics CDMO Services Forecasted Market Size by Type (2025-2030)
5 Biologics CDMO Services Breakdown Data by Application
5.1 Global Biologics CDMO Services Historic Market Size by Application (2019-2024)
5.2 Global Biologics CDMO Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biologics CDMO Services Market Size (2019-2030)
6.2 North America Biologics CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biologics CDMO Services Market Size by Country (2019-2024)
6.4 North America Biologics CDMO Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics CDMO Services Market Size (2019-2030)
7.2 Europe Biologics CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biologics CDMO Services Market Size by Country (2019-2024)
7.4 Europe Biologics CDMO Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics CDMO Services Market Size (2019-2030)
8.2 Asia-Pacific Biologics CDMO Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biologics CDMO Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Biologics CDMO Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics CDMO Services Market Size (2019-2030)
9.2 Latin America Biologics CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biologics CDMO Services Market Size by Country (2019-2024)
9.4 Latin America Biologics CDMO Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics CDMO Services Market Size (2019-2030)
10.2 Middle East & Africa Biologics CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biologics CDMO Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Biologics CDMO Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Biologics CDMO Services Introduction
11.1.4 Lonza Revenue in Biologics CDMO Services Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Biologics CDMO Services Introduction
11.2.4 Catalent Revenue in Biologics CDMO Services Business (2019-2024)
11.2.5 Catalent Recent Development
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Detail
11.3.2 Samsung Biologics Business Overview
11.3.3 Samsung Biologics Biologics CDMO Services Introduction
11.3.4 Samsung Biologics Revenue in Biologics CDMO Services Business (2019-2024)
11.3.5 Samsung Biologics Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Biologics CDMO Services Business (2019-2024)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Biologics CDMO Services Introduction
11.5.4 Boehringer Ingelheim Revenue in Biologics CDMO Services Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Development
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Detail
11.6.2 WuXi AppTech Business Overview
11.6.3 WuXi AppTech Biologics CDMO Services Introduction
11.6.4 WuXi AppTech Revenue in Biologics CDMO Services Business (2019-2024)
11.6.5 WuXi AppTech Recent Development
11.7 Recipharm
11.7.1 Recipharm Company Detail
11.7.2 Recipharm Business Overview
11.7.3 Recipharm Biologics CDMO Services Introduction
11.7.4 Recipharm Revenue in Biologics CDMO Services Business (2019-2024)
11.7.5 Recipharm Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Biologics CDMO Services Introduction
11.8.4 Thermo Fisher Scientific Revenue in Biologics CDMO Services Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 AGC Biologics
11.9.1 AGC Biologics Company Detail
11.9.2 AGC Biologics Business Overview
11.9.3 AGC Biologics Biologics CDMO Services Introduction
11.9.4 AGC Biologics Revenue in Biologics CDMO Services Business (2019-2024)
11.9.5 AGC Biologics Recent Development
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Detail
11.10.2 Rentschler Biopharma Business Overview
11.10.3 Rentschler Biopharma Biologics CDMO Services Introduction
11.10.4 Rentschler Biopharma Revenue in Biologics CDMO Services Business (2019-2024)
11.10.5 Rentschler Biopharma Recent Development
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Detail
11.11.2 KBI Biopharma Business Overview
11.11.3 KBI Biopharma Biologics CDMO Services Introduction
11.11.4 KBI Biopharma Revenue in Biologics CDMO Services Business (2019-2024)
11.11.5 KBI Biopharma Recent Development
11.12 Siegfried
11.12.1 Siegfried Company Detail
11.12.2 Siegfried Business Overview
11.12.3 Siegfried Biologics CDMO Services Introduction
11.12.4 Siegfried Revenue in Biologics CDMO Services Business (2019-2024)
11.12.5 Siegfried Recent Development
11.13 Aenova Group
11.13.1 Aenova Group Company Detail
11.13.2 Aenova Group Business Overview
11.13.3 Aenova Group Biologics CDMO Services Introduction
11.13.4 Aenova Group Revenue in Biologics CDMO Services Business (2019-2024)
11.13.5 Aenova Group Recent Development
11.14 GenScript
11.14.1 GenScript Company Detail
11.14.2 GenScript Business Overview
11.14.3 GenScript Biologics CDMO Services Introduction
11.14.4 GenScript Revenue in Biologics CDMO Services Business (2019-2024)
11.14.5 GenScript Recent Development
11.15 ProBioGen
11.15.1 ProBioGen Company Detail
11.15.2 ProBioGen Business Overview
11.15.3 ProBioGen Biologics CDMO Services Introduction
11.15.4 ProBioGen Revenue in Biologics CDMO Services Business (2019-2024)
11.15.5 ProBioGen Recent Development
11.16 Northway Biotech
11.16.1 Northway Biotech Company Detail
11.16.2 Northway Biotech Business Overview
11.16.3 Northway Biotech Biologics CDMO Services Introduction
11.16.4 Northway Biotech Revenue in Biologics CDMO Services Business (2019-2024)
11.16.5 Northway Biotech Recent Development
11.17 3P Biopharmaceuticals
11.17.1 3P Biopharmaceuticals Company Detail
11.17.2 3P Biopharmaceuticals Business Overview
11.17.3 3P Biopharmaceuticals Biologics CDMO Services Introduction
11.17.4 3P Biopharmaceuticals Revenue in Biologics CDMO Services Business (2019-2024)
11.17.5 3P Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Biologics CDMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cell and Gene Therapies
Table 3. Key Players of Antibodies
Table 4. Key Players of Vaccines
Table 5. Key Players of Other
Table 6. Global Biologics CDMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Biologics CDMO Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Biologics CDMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Biologics CDMO Services Market Share by Region (2019-2024)
Table 10. Global Biologics CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Biologics CDMO Services Market Share by Region (2025-2030)
Table 12. Biologics CDMO Services Market Trends
Table 13. Biologics CDMO Services Market Drivers
Table 14. Biologics CDMO Services Market Challenges
Table 15. Biologics CDMO Services Market Restraints
Table 16. Global Biologics CDMO Services Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Biologics CDMO Services Market Share by Players (2019-2024)
Table 18. Global Top Biologics CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics CDMO Services as of 2023)
Table 19. Ranking of Global Top Biologics CDMO Services Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Biologics CDMO Services Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Biologics CDMO Services Product Solution and Service
Table 23. Date of Enter into Biologics CDMO Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biologics CDMO Services Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Biologics CDMO Services Revenue Market Share by Type (2019-2024)
Table 27. Global Biologics CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Biologics CDMO Services Revenue Market Share by Type (2025-2030)
Table 29. Global Biologics CDMO Services Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Biologics CDMO Services Revenue Market Share by Application (2019-2024)
Table 31. Global Biologics CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Biologics CDMO Services Revenue Market Share by Application (2025-2030)
Table 33. North America Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Biologics CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Biologics CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Biologics CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Biologics CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Biologics CDMO Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Biologics CDMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Biologics CDMO Services Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Biologics CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Biologics CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Biologics CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Biologics CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 48. Lonza Company Detail
Table 49. Lonza Business Overview
Table 50. Lonza Biologics CDMO Services Product
Table 51. Lonza Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 52. Lonza Recent Development
Table 53. Catalent Company Detail
Table 54. Catalent Business Overview
Table 55. Catalent Biologics CDMO Services Product
Table 56. Catalent Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 57. Catalent Recent Development
Table 58. Samsung Biologics Company Detail
Table 59. Samsung Biologics Business Overview
Table 60. Samsung Biologics Biologics CDMO Services Product
Table 61. Samsung Biologics Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 62. Samsung Biologics Recent Development
Table 63. FUJIFILM Diosynth Biotechnologies Company Detail
Table 64. FUJIFILM Diosynth Biotechnologies Business Overview
Table 65. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product
Table 66. FUJIFILM Diosynth Biotechnologies Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 67. FUJIFILM Diosynth Biotechnologies Recent Development
Table 68. Boehringer Ingelheim Company Detail
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Biologics CDMO Services Product
Table 71. Boehringer Ingelheim Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. WuXi AppTech Company Detail
Table 74. WuXi AppTech Business Overview
Table 75. WuXi AppTech Biologics CDMO Services Product
Table 76. WuXi AppTech Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 77. WuXi AppTech Recent Development
Table 78. Recipharm Company Detail
Table 79. Recipharm Business Overview
Table 80. Recipharm Biologics CDMO Services Product
Table 81. Recipharm Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 82. Recipharm Recent Development
Table 83. Thermo Fisher Scientific Company Detail
Table 84. Thermo Fisher Scientific Business Overview
Table 85. Thermo Fisher Scientific Biologics CDMO Services Product
Table 86. Thermo Fisher Scientific Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 87. Thermo Fisher Scientific Recent Development
Table 88. AGC Biologics Company Detail
Table 89. AGC Biologics Business Overview
Table 90. AGC Biologics Biologics CDMO Services Product
Table 91. AGC Biologics Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 92. AGC Biologics Recent Development
Table 93. Rentschler Biopharma Company Detail
Table 94. Rentschler Biopharma Business Overview
Table 95. Rentschler Biopharma Biologics CDMO Services Product
Table 96. Rentschler Biopharma Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 97. Rentschler Biopharma Recent Development
Table 98. KBI Biopharma Company Detail
Table 99. KBI Biopharma Business Overview
Table 100. KBI Biopharma Biologics CDMO Services Product
Table 101. KBI Biopharma Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 102. KBI Biopharma Recent Development
Table 103. Siegfried Company Detail
Table 104. Siegfried Business Overview
Table 105. Siegfried Biologics CDMO Services Product
Table 106. Siegfried Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 107. Siegfried Recent Development
Table 108. Aenova Group Company Detail
Table 109. Aenova Group Business Overview
Table 110. Aenova Group Biologics CDMO Services Product
Table 111. Aenova Group Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 112. Aenova Group Recent Development
Table 113. GenScript Company Detail
Table 114. GenScript Business Overview
Table 115. GenScript Biologics CDMO Services Product
Table 116. GenScript Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 117. GenScript Recent Development
Table 118. ProBioGen Company Detail
Table 119. ProBioGen Business Overview
Table 120. ProBioGen Biologics CDMO Services Product
Table 121. ProBioGen Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 122. ProBioGen Recent Development
Table 123. Northway Biotech Company Detail
Table 124. Northway Biotech Business Overview
Table 125. Northway Biotech Biologics CDMO Services Product
Table 126. Northway Biotech Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 127. Northway Biotech Recent Development
Table 128. 3P Biopharmaceuticals Company Detail
Table 129. 3P Biopharmaceuticals Business Overview
Table 130. 3P Biopharmaceuticals Biologics CDMO Services Product
Table 131. 3P Biopharmaceuticals Revenue in Biologics CDMO Services Business (2019-2024) & (US$ Million)
Table 132. 3P Biopharmaceuticals Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologics CDMO Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biologics CDMO Services Market Share by Type: 2023 VS 2030
Figure 3. Cell and Gene Therapies Features
Figure 4. Antibodies Features
Figure 5. Vaccines Features
Figure 6. Other Features
Figure 7. Global Biologics CDMO Services Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Biologics CDMO Services Market Share by Application: 2023 VS 2030
Figure 9. SMBs Case Studies
Figure 10. Large Companies Case Studies
Figure 11. Biologics CDMO Services Report Years Considered
Figure 12. Global Biologics CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Biologics CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Biologics CDMO Services Market Share by Region: 2023 VS 2030
Figure 15. Global Biologics CDMO Services Market Share by Players in 2023
Figure 16. Global Top Biologics CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics CDMO Services as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Biologics CDMO Services Revenue in 2023
Figure 18. North America Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Biologics CDMO Services Market Share by Country (2019-2030)
Figure 20. United States Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Biologics CDMO Services Market Share by Country (2019-2030)
Figure 24. Germany Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Biologics CDMO Services Market Share by Region (2019-2030)
Figure 32. China Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Biologics CDMO Services Market Share by Country (2019-2030)
Figure 40. Mexico Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Biologics CDMO Services Market Share by Country (2019-2030)
Figure 44. Turkey Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Biologics CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Lonza Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 47. Catalent Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 48. Samsung Biologics Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 49. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 51. WuXi AppTech Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 52. Recipharm Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 54. AGC Biologics Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 55. Rentschler Biopharma Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 56. KBI Biopharma Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 57. Siegfried Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 58. Aenova Group Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 59. GenScript Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 60. ProBioGen Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 61. Northway Biotech Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 62. 3P Biopharmaceuticals Revenue Growth Rate in Biologics CDMO Services Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
